_version_ 1784762537714122752
author Lenk, Lennart
Winterberg, Dorothee
Vogiatzi, Fotini
Laqua, Anna
Spory, Lea
Mayar, Ahmad
Dietterle, Anna
Münch, Gina
Vokuhl, Christian
Richter, Julia
Polson, Andrew G.
Schüler, Thomas
Kahlert, Ulf D.
Peipp, Matthias
Valerius, Thomas
Schrappe, Martin
Cario, Gunnar
Jumaa, Hassan
Hobeika, Elias
Brüggemann, Monika
Alsadeq, Ameera
Schewe, Denis M.
author_facet Lenk, Lennart
Winterberg, Dorothee
Vogiatzi, Fotini
Laqua, Anna
Spory, Lea
Mayar, Ahmad
Dietterle, Anna
Münch, Gina
Vokuhl, Christian
Richter, Julia
Polson, Andrew G.
Schüler, Thomas
Kahlert, Ulf D.
Peipp, Matthias
Valerius, Thomas
Schrappe, Martin
Cario, Gunnar
Jumaa, Hassan
Hobeika, Elias
Brüggemann, Monika
Alsadeq, Ameera
Schewe, Denis M.
author_sort Lenk, Lennart
collection PubMed
description
format Online
Article
Text
id pubmed-9351922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93519222022-08-05 Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia Lenk, Lennart Winterberg, Dorothee Vogiatzi, Fotini Laqua, Anna Spory, Lea Mayar, Ahmad Dietterle, Anna Münch, Gina Vokuhl, Christian Richter, Julia Polson, Andrew G. Schüler, Thomas Kahlert, Ulf D. Peipp, Matthias Valerius, Thomas Schrappe, Martin Cario, Gunnar Jumaa, Hassan Hobeika, Elias Brüggemann, Monika Alsadeq, Ameera Schewe, Denis M. Hemasphere Letter Lippincott Williams & Wilkins 2022-07-15 /pmc/articles/PMC9351922/ /pubmed/35935606 http://dx.doi.org/10.1097/HS9.0000000000000754 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Lenk, Lennart
Winterberg, Dorothee
Vogiatzi, Fotini
Laqua, Anna
Spory, Lea
Mayar, Ahmad
Dietterle, Anna
Münch, Gina
Vokuhl, Christian
Richter, Julia
Polson, Andrew G.
Schüler, Thomas
Kahlert, Ulf D.
Peipp, Matthias
Valerius, Thomas
Schrappe, Martin
Cario, Gunnar
Jumaa, Hassan
Hobeika, Elias
Brüggemann, Monika
Alsadeq, Ameera
Schewe, Denis M.
Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
title Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
title_full Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
title_fullStr Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
title_full_unstemmed Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
title_short Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
title_sort preclinical evidence for the efficacy of cd79b immunotherapy in b-cell precursor acute lymphoblastic leukemia
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351922/
https://www.ncbi.nlm.nih.gov/pubmed/35935606
http://dx.doi.org/10.1097/HS9.0000000000000754
work_keys_str_mv AT lenklennart preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT winterbergdorothee preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT vogiatzifotini preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT laquaanna preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT sporylea preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT mayarahmad preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT dietterleanna preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT munchgina preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT vokuhlchristian preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT richterjulia preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT polsonandrewg preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT schulerthomas preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT kahlertulfd preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT peippmatthias preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT valeriusthomas preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT schrappemartin preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT cariogunnar preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT jumaahassan preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT hobeikaelias preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT bruggemannmonika preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT alsadeqameera preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia
AT schewedenism preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia